FindTrial
Sign In

Serious Infections after Tocilizumab Administration in Patients with Rheumatoid Arthritis: A Retrospective Study Using an Adverse Drug Reaction Database -Analysis of Clinical Symptoms and Laboratory Test Data in Serious Infections-

Serious Infections after Tocilizumab Administration in Patients with Rheumatoid Arthritis: A Retrospective Study Using an Adverse Drug Reaction Database -Analysis of Clinical Symptoms and Laboratory Test Data in Serious Infections- - Serious Infections after Tocilizumab Administration in Patients with Rheumatoid Arthritis: A Retrospective Study Using an Adverse Drug Reaction Database -Analysis of Clinical Symptoms and Laboratory Test Data in Serious Infections-

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000024071
Enrollment
7653
Registered
2016-09-16
Start date
2016-03-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Interventions

None listed

Sponsors

CHUGAI PHARMACEUTICAL CO.,LTD. DRUG SAFTY DATA MANAGEMENT DEPT.
Lead Sponsor
HOKKAIDO UNIVERSITY
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who developed serious infections for which a causal relationship could not be ruled out.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
To identify the initial symptoms before developing serious infection (SI) in the TCZ treated patients by using the clinical narratives from Post-marketing adverse events reporting database.—

Countries

Japan

Contacts

Public ContactAndo,Yoshiaki

CHUGAI PHARMACEUTICAL CO.,LTD. DRUG SAFTY DATA MANAGEMENT DEPT.

ando.yoshiaki20@chugai-pharm.co.jp03-3273-0938

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026